Other News To Note
Tuesday, December 28, 2010
King Pharmaceuticals Inc., of Bristol, Tenn., resubmitted its new drug application for Remoxy, a twice-daily formulation of oxycodone, to the FDA, following a review 2008 letter from the FDA.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.